Universal Biosensors Inc
Research Universal Biosensors Inc (UBI) on Bullrun: market cap AUD 4.17M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerUBI
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 4.17M
- Financial periodQ2 2025
- RevenueAUD 1.21M
- Net income-AUD 6.61M
- Free cash flow-AUD 2.14M
- Gross margin-99.8%
Valuation Snapshot
latest market cap is AUD 4.17M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | AUD 4.17M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Universal Biosensors Inc
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Universal Biosensors Inc's market cap?
Universal Biosensors Inc's market capitalization is AUD 4.17M.
What does Universal Biosensors Inc do?
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO2, malic acid, glucose, fructose, total acid, and titratable acidity.